We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

96 hedge funds and large institutions have $223M invested in BioSpecifics Technologies Corp. in 2016 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 37 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

29% more capital invested

Capital invested by funds: $174M → $223M (+$49.8M)

7% more funds holding

Funds holding: 90 → 96 (+6)

8% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 37

Holders
96
Holders Change
+6
Holders Change %
+6.67%
% of All Funds
2.4%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
16
Increased
34
Reduced
37
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
+$7.41M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.48M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.45M
4
MCM
Matarin Capital Management
New York
+$1.45M
5
BFA
BlackRock Fund Advisors
California
+$1.23M

Top Sellers

Rank Fund Capital Flow
1
RCMC
RK Capital Management (Colorado)
Colorado
-$3.74M
2
DCM
DAFNA Capital Management
California
-$1.81M
3
RA
Royce & Associates
New York
-$1.47M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$877K
5
BCM
Bridgeway Capital Management
Texas
-$846K
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
26
Matarin Capital Management
New York
$2.64M +$1.45M +30,088 +173%
OAM
27
Oxford Asset Management
United Kingdom
$2.57M -$507K -10,558 -19%
RA
28
Royce & Associates
New York
$2.51M -$1.47M -30,600 -40%
GCP
29
GSA Capital Partners
United Kingdom
$2.41M -$327K -6,800 -14%
Charles Schwab
30
Charles Schwab
California
$2.4M -$81.7K -1,700 -4%
First Manhattan
31
First Manhattan
New York
$2.29M -$106K -2,200 -5%
SEI Investments
32
SEI Investments
Pennsylvania
$2.2M +$644K +13,400 New
TCIM
33
TIAA CREF Investment Management
New York
$1.93M -$4.76K -99 -0.3%
GC
34
Globeflex Capital
California
$1.93M -$24K -500 -1%
PNC Financial Services Group
35
PNC Financial Services Group
Pennsylvania
$1.89M -$35.3K -734 -2%
FQ
36
First Quadrant
California
$1.88M +$847K +17,617 +109%
PI
37
Putnam Investments
Massachusetts
$1.83M -$14.1K -294 -0.9%
TC
38
TFS Capital
Pennsylvania
$1.83M -$365K -7,596 -19%
American Century Companies
39
American Century Companies
Missouri
$1.83M -$110K -2,297 -7%
Russell Investments Group
40
Russell Investments Group
United Kingdom
$1.66M +$1.46M +30,280 New
Two Sigma Investments
41
Two Sigma Investments
New York
$1.56M -$654K -13,613 -33%
BA
42
BlackRock Advisors
Delaware
$1.43M -$18.5K -384 -1%
Two Sigma Advisers
43
Two Sigma Advisers
New York
$1.23M -$19.2K -400 -2%
CCM
44
Cadence Capital Management
Massachusetts
$1.21M +$25.3K +526 +2%
BIM
45
BlackRock Investment Management
Delaware
$1.19M +$9.28K +193 +0.9%
CI
46
Cigna Investments
Connecticut
$1.19M +$1.03M +21,368 New
ACM
47
Ativo Capital Management
Illinois
$1.09M – – –
Morgan Stanley
48
Morgan Stanley
New York
$1.03M +$788K +16,403 +750%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$990K – – –
SCA
50
Secor Capital Advisors
New York
$988K -$228K -4,749 -21%
1
2
3 4 5

BSTC Hedge Fund Activity: Q4 2016 in Review

96 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2016, worth a combined $223M — up 29% from $174M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BSTC positions and 9 closed out — a net gain of 7 holders — while 34 added to existing stakes and 37 trimmed.

The largest buyer was Numeric Investors, opening a new position worth an estimated $7.41M. The largest seller was RK Capital Management (Colorado), cutting an estimated $3.74M.

  • 96 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q4 2016, up from 90 in Q3 2016.
  • Funds reported $223M of BioSpecifics Technologies Corp. stock for Q4 2016, up 29% quarter-over-quarter.
  • 16 funds opened new BioSpecifics Technologies Corp. positions in Q4 2016 and 9 closed out, a net change of +7 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q4 2016 was Numeric Investors, an estimated $7.41M added.
  • The largest BioSpecifics Technologies Corp. seller in Q4 2016 was RK Capital Management (Colorado), an estimated $3.74M sold.

Based on aggregated 13F filings for Q4 2016.